Cerity Partners’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-844	Closed	-$49K	–	537
2018 Q2	$49K	Hold	844	–	–	﹤0.01%	532
2018 Q1	$40K	Buy	+844	New	+$40K	﹤0.01%	518